About this episode
BMO Capital Markets analyst Evan Seigerman discusses the Trump Administration's deal with Big Pharma. Plus, meet the Suspicious 8, with 6% dividends and lots of problems.
Learn more about your ad choices. Visit megaphone.fm/adchoices
